http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200502204-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
filingDate 2004-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8510c42704234abd73b3155f1dbccf0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_237371d481c1aaa6fd2e1332c381e89e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a66d2503c7c0626a60cbeb7eade53b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92fff26c96db81316bdf9afb77d52e5b
publicationDate 2005-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-200502204-A
titleOfInvention Oligo acid derivatives
abstract The present invention provides an oligosaccharide derivative of the following fomula(I) or its salt or its ester, which has an excellent activity and a safety, and is useful as a medicament for prophylactic or therapeutic treating diabetes (wherein, ring A is a cyclic ring etc., R1 and R2 are the same or differrent, each represents an alkyl group, a hydroxymethyl group, n is 1 or 2).
priorityDate 2003-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482

Total number of triples: 30.